CURIS, INC. Total Long-Term Debt
CURIS, INC. (CRIS) had Total Long-Term Debt of $900.00 thousand as of 2020-04-30, per its 10-K filed 2023-03-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2023-03-13
- 2020-04-30: Long-term Debt $900.00K.
- 2020-04-21: Long-term Debt $900.00K.
- 2019-12-31: Long-term Debt $0.00.
| Period end | Long-term Debt |
|---|---|
| 2020-04-30 | $900.00K 10-K · filed 2023-03-13 |
| 2020-04-21 | $900.00K 10-Q · filed 2021-05-12 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |